Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Lymph Node Metastases Diagnosed by 18F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy

ICHIRO OGINO, SHIGENOBU WATANABE, TOSHIHIRO MISUMI, MASAHARU HATA and CHIKARA KUNISAKI
Anticancer Research September 2019, 39 (9) 4977-4985; DOI: https://doi.org/10.21873/anticanres.13687
ICHIRO OGINO
1Department of Radiation Oncology, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ogino1ro@yokohama-cu.ac.jp
SHIGENOBU WATANABE
1Department of Radiation Oncology, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIHIRO MISUMI
2Department of Biostatistics, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHARU HATA
3Division of Radiation Oncology, Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIKARA KUNISAKI
4Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 39 no. 9 4977-4985
DOI 
https://doi.org/10.21873/anticanres.13687
PubMed 
31519604

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 25, 2019
  • Revision received July 13, 2019
  • Accepted July 15, 2019
  • Published online September 13, 2019.

Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ICHIRO OGINO1⇑,
  2. SHIGENOBU WATANABE1,
  3. TOSHIHIRO MISUMI2,
  4. MASAHARU HATA3 and
  5. CHIKARA KUNISAKI4
  1. 1Department of Radiation Oncology, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
  2. 2Department of Biostatistics, Yokohama City University, Yokohama, Japan
  3. 3Division of Radiation Oncology, Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
  4. 4Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
  1. Correspondence to: Ichiro Ogino, MD, Department of Radiation Oncology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa 232-0024, Japan. Tel: +81 452615656, e-mail: ogino1ro{at}yokohama-cu.ac.jp
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 39 (9)
Anticancer Research
Vol. 39, Issue 9
September 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lymph Node Metastases Diagnosed by 18F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Lymph Node Metastases Diagnosed by 18F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy
ICHIRO OGINO, SHIGENOBU WATANABE, TOSHIHIRO MISUMI, MASAHARU HATA, CHIKARA KUNISAKI
Anticancer Research Sep 2019, 39 (9) 4977-4985; DOI: 10.21873/anticanres.13687

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Lymph Node Metastases Diagnosed by 18F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy
ICHIRO OGINO, SHIGENOBU WATANABE, TOSHIHIRO MISUMI, MASAHARU HATA, CHIKARA KUNISAKI
Anticancer Research Sep 2019, 39 (9) 4977-4985; DOI: 10.21873/anticanres.13687
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Skeletal Muscle Mass Before Second-line Chemotherapy Correlates With Subsequent Prognosis and Rate of Late-line Chemotherapy in Patients With Unresectable Gastric Cancer
  • Revisiting the Prognostic Impact of Family History in Colorectal Cancer by Retrospective Propensity Score Matching
  • Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
Show more Clinical Studies

Similar Articles

Keywords

  • Location of lymph node
  • positron emission tomography/computed tomography
  • Esophageal squamous cell carcinoma
  • staging
  • Concurrent chemoradiotherapy
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire